2012 US Blood Banking Market Strategic Analysis: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests

June 2012 | 460 pages | ID: FE1D2EA1BA7EN
Venture Planning Group

Abstracts

Thisreport presents a comprehensive analysis of the US blood banking market, including:

• Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues.
• Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, hospitals, commercial laboratories, and plasma fractionation facilities.
• Annual placements and installed base estimates for major automated and semiautomated analyzers.
• Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.
• Ten-year reagent and instrument sales forecasts.
• Sales and market shares of leading reagent and instrument suppliers.
• Review of current and emerging technologies, and their potential market applications.
• Product development opportunities for instruments ,consumables, and auxiliary products.
• Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Contains 460 pages and 53 tables

Contents

WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. Blood Typing and Grouping Tests
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. Infectious Disease Screening Tests
    a. AIDS
      Structure and Composition
      Classification
      HIV-1/2-2 Infection
      Origin of AIDS
      Animal Lentivirus Systems
      Virus Receptors
      HIV-1/2 Infections in Humans
        Pathogenesis & Pathology
        Overview of Course of HIV-1/2 Infection
      CD4T Lymphocytes and Memory Cells
      Monocytes and Macrophages
      Lymphoid Organs
      Neural Cells
      Viral Coinfections
        Clinical Findings
      Plasma Viral Load
      Pediactric AIDS
        Neurologic Disease
        Opportunistic Infections
        Protozoa
        Fungi
        Bacteria
        Viruses
        Cancer
      Immunity
      Laboratory Diagnosis
        Virus Isolation
        Serology
        Detection of Viral Nucleic Acid or Antigens
      Epidemiology
        Worldwide Spread of AIDS
        United States
        Routes of Transmission
      Prevention, Treatment, And Control
        Antiviral Drugs
        Vaccines Against HIV-1/2
      Transmission of HIV-1/2 in Blood Products
      HIV-1/2 Transmission in Transplant and Artificial Insemination Recipients
      Diagnostic Tests
        Enzyme Immunoassay Interpretation
        Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
      Competition Assays
      Western Blot Technique
      Immuno-Fluorescence Assay (IFA)
      Radioimmunoprecipitation
      HIV-1/2-1/HIV-1/2-2 Combination Testing
      Methods of HIV-1/2-Antigen Detection
      Antigen Assays and Blood Screening
      Urine Tests
      DNA Probes
      Overview
      Quantitative Polymerase Chain Reaction
      In Situ PCR
      Needed Improvements
      Viral Load/Drug Resistance Testing
      Genotype and Phenotype Testing
      Blood Banking Considerations
    b. Hepatitis
      Hepatitis A
      Hepatitis B
        Structure and Composition
        Replication of Hepatitis B Virus
      Hepatitis C
      Hepatitis D (Delta Hepatitis)
      Hepatitis E
      Hepatitis G
      Hepatitis Virus Infections In Humans
        Pathology
      Clinical Findings
      Laboratory Features
        Hepatitis A
        Hepatitis B
        Hepatitis C
        Hepatitis D
        Hepatitis E
      Virus-Host Immune Reactions
      Epidemiology
        Hepatitis A
        Hepatitis B
        Hepatitis C
        Hepatitis D (Delta Agent)
      Vaccines and Drugs
    c. Cytomegalovirus
      Background
      Chorioretinitis
      Gastrointestinal
      Central Nervous System Disease
      Diagnostic Tests
      Vaccines and Drugs
    d. Syphilis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    e. West Nile Virus
      Background
      Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
    f. Parvovirus B19
      Microbiology
      Epidemiology
      Clinical Syndromes
        Erythema Infectiosum Slapped (cheek)
        Adult Polyarthropathy
        Transient Aplastic Crisis
        Transient Pancytopenia
        Red Cell Aplasia in the Immunocompromised
        Perinatal Infections
      Diagnosis
      Treatment
    g. Creutzfeldt-Jakob’s Disease
      Background
      Transmission
      Diagnostic Tests
      Major Commercial and Academic Players
        Bayer
        Disease Sciences/BioTec Global
        Imperial College School of Medicine
        Ortho-Clinical Diagnostics
        Pall
        ProMetic Life Sciences
        Proteome Sciences/Idexx
        Q-One Biotech
        Serono
        U.S. Agricultural Research Service
      Drugs
      Vaccines
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  3. Pathogen Reduction
  4. Leukocyte Reduction
      Background
      Methods
B. Instrumentation Review
Introduction
  1. Abbott Prism
  2. Abbott Quantum II
  3. Abbott Commander
  4. BioMeriuex BacT/Alert
  5. Dade Behring Quadriga
  6. Dade Behring BEP 2000
  7. Grifols Diana
  8. Immucor ABS2000
  8. Immucor Galile
  10. Immucor Rosys Plato
  11. Olympus PK7100
  12. Olympus PK7200
  13. Olympus PK80
  14. Olympus BloodTrack Courier
  15. Ortho AutoVue/ProVue
  16. Ortho Summit Processor
  17. Tecan ELPHAtyper
  18. Tecan Hemotyper
  19. Tecan MegaFlex
  20. Tecan MiniSwift
C. Major in Vitro Diagnostic Technologies And Their Potential Applications
  1. Molecular Diagnostics
    a. Overview
    b. NAT
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescence Polarization
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microtitration Plates
  5. Microcomputers
  6. Automation
  7. Lasers
  8. Robotics
  9. Artificial Intelligence
  10. Synthetic Red Cell Substitutes
  11. Genetically Engineered Blood Components
    a. Albumin
    b. Factor VIII
    c. Alpha-2 Antiplasmin
    d. Antithrombin III
    e. Factor IX
    f. Von Willebrand's Factor
    g. Fibrinogen
    h. t-PA
  12. Blood Preservation
  13. Autologous Blood Transfusion/Freezing
D. Worldwide Market Overview
  1. Business Environment
  2. Market Structure
  3. Market Size and Growth

U.S.A.

A. Executive Summary
B. Business Environment
  1. Overview
  2. Health Care Expenditures
  3. Cost Consciousness
  4. Reimbursement
  5. Industry Consolidation
  6. Managed Care
    a. HMO
    b. PPO
  7. Hospitals
  8. Admissions
  9. Length of Stay
  10. Industry Diversification
  11. Physician Demographics
  12. Population Aging
    a. Chronic Illnesses
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  13. Laboratory Regulations
  14. FDA Reform

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints

COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter
Biokit
BioMerieux
Bio-Rad
Bioscot
Biotest
Chiron
Diagast
Diamed
DiaSorin
Fujirebio
Gen-Probe
Gradipore
Grifols
ImmucorGamma
Innogenetics
Orchid Biosciences
Ortho-Clinical Diagnostics
Proteome Sciences
Roche
Siemens
Tecan
Appendix: Assumed Currency Exchange Rates

List Of Tables

LIST OF TABLES
Table II-1: Major Companies Developing or Marketing Blood Typing and Grouping Tests
Table II-2: Major Companies Developing or Marketing HLA Typing Tests
Table II&-3: Major Companies Developing or Marketing AIDS Tests
Table II-4: Major Companies Developing or Marketing Hepatitis Tests
Table II-5: Major Companies Developing or Marketing CMV Tests
Table II-6: Major Companies Developing or Marketing Syphilis Tests
Table II-7: Major Companies Developing or Marketing Blood Bank Analyzers
Table II-8: Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country
Table II-9: Worldwide, All Market Segments, Blood Typing and Grouping Test Volume By Country
Table II-10: Worldwide, All Market Segments, Infectious Disease Screening Test Volume
Table II-11: Worldwide, All Market Segments, Blood Typing and Grouping Reagent Market By Country
Table II-12: Worldwide, All Market Segments, Infectious Disease Reagent Market By Country
Executive Summary Table: U.S.A., Blood Bank Test Volume and Reagent Sales By Test Category
Table IX-1: U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
Table IX-2: U.S.A., Facilities Performing Blood Bank Tests By Market Segment
Table IX-3: U.S.A., Hospital Laboratories Performing Blood Bank Tests By Bed Size
Table IX-4: U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests By Annual Test Volume
Table IX-5: U.S.A., Facilities Collecting Whole Blood and Plasma By Market Segment
Table IX-6: U.S.A., Whole Blood and Plasma Collections By Market Segment
Table IX-7: U.S.A., Blood Typing and Grouping Test Volume By Market Segment
Table IX-8: U.S.A., All Market Segments Blood Typing and Grouping Test Volume
Table IX-9: U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume
Table IX-10: U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume
Table IX-11: U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume
Table IX-12: U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume
Table IX-13: U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume
Table IX-14: U.S.A., Infectious Disease Screening Test Volume By Market Segment
Table IX-15: U.S.A., All Market Segments Infectious Disease Screening Test Volume
Table IX-16: U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume
Table IX-17: U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume
Table IX-18: U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume
Table IX-19: U.S.A., Military Blood Banks Infectious Disease Screening Test Volume
Table IX-20: U.S.A., All Market Segments Blood Typing and Grouping Reagent Market By Market Segment
Table IX-21: U.S.A., Blood Typing and Grouping Reagent Market By Market Segment
Table IX-22: U.S.A., Hospital Blood Banks Blood Typing and Grouping Reagent Market by Major Test
Table IX-23: U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market By Major Test
Table IX-24: U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market By Major Test
Table IX-25: U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market By Major Test
Table IX-26: U.S.A., Military Blood Banks Blood Typing and Grouping Reagent Market By Major Test
Table IX-27: U.S.A., Infectious Disease Screening Reagent Market By Market Segment
Table IX-28: U.S.A., All Market Segments Infectious Disease Screening Reagent Market By Market Segment
Table IX-29: U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market By Test
Table IX-30: U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market By Test
Table IX-31: U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market By Test
Table IX-32: U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market By Test
Table IX-33: U.S.A., Major Suppliers of Blood Typing and Grouping Reagents, Estimated Sales and Market Shares
Table IX-34: U.S.A., HIV-1/2/HTLV Blood Screening Market by Major Supplier
Table IX-35: U.S.A., Hepatitis Blood Screening Market by Major Supplier
Table IX-36: U.S.A., Hepatitis C Blood Screening Market By Major Supplier
Table IX-37: U.S.A., HIV-1/2/Hepatitis C NAT Blood Screening Market By Major Supplier
Table IX-38: U.S.A., West Nile Virus NAT Blood Screening Market By Major Supplier
Table IX-39: U.S.A., CMV Blood Screening Market By Major Supplier
Table IX-40: U.S.A., Syphilis Blood Screening Market By Major Supplier
Table IX-41: U.S.A. Major Suppliers of Blood Bank Automated Analyzers, Estimated Placements and Installed Base